Benzinga - by Benzinga Insights, Benzinga Staff Writer.
Altimmune (NASDAQ:ALT) has outperformed the market over the past 5 years by 24.97% on an annualized basis producing an average annual return of 37.62%. Currently, Altimmune has a market capitalization of $706.53 million.
Buying $100 In ALT: If an investor had bought $100 of ALT stock 5 years ago, it would be worth $499.25 today based on a price of $13.15 for ALT at the time of writing.
Altimmune's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.